Overexpression of E2F-1 leads to bax-independent cell death in human glioma cells

Loading...
Thumbnail Image

Date

Authors

Mitlianga, P. G.
Gomez-Manzano, C.
Kyritsis, A. P.
Fueyo, J.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

Int J Oncol

Book name

Book series

Book edition

Alternative title / Subtitle

Description

Gliomas are highly resistant to any kind of treatment. Multiple genetic abnormalities exist in gliomas indicating that effective gene therapy should be directed towards replacement of multiple rather than single genes. Bax is a protein of the Bcl-2 family that promotes apoptosis and functions as a tumor suppressor gene. The E2F family of transcription factors plays a pivotal role in the regulation of cell-cycle and cell-death related genes in gliomas. We examined the therapeutic potential of the simultaneous transfer of Bax and E2F molecules (1, 2 or 4) to gliomas. We used first generation E1A-deleted adenoviral vectors to transduce the E2Fs and Bax cDNAs. The recombinant adenoviral vector encoding bax uses the inducible Cre-loxP system to transduce the protein expression. Western blot analysis and immunofluorescence assays demonstrated high level of expression of the exogenous proteins. Trypan blue cell viability assays and flow cytometric cell-cycle analysis demonstrated an additive effect of these molecules to induce cell death via apoptosis. Western blot analysis showed that the ectopic expression of E2F-1 decreased the level of expression of Bax. These results indicate that E2F-1 and Bax have an additive anti-glioma effect when expressed simultaneously at high levels. Our data also suggest that Bax is not involved in the E2F-1-mediated apoptosis.

Description

Keywords

Adenoviridae/genetics, *Apoptosis, *Cell Cycle Proteins, Cell Survival, *DNA-Binding Proteins, E2F Transcription Factors, E2F1 Transcription Factor, *Gene Therapy, Glioma/chemistry/pathology/*therapy, Humans, Proto-Oncogene Proteins/analysis/*genetics/physiology, *Proto-Oncogene Proteins c-bcl-2, Transcription Factors/analysis/*genetics/physiology, Tumor Cells, Cultured, bcl-2-Associated X Protein

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/12370749

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By